Literature DB >> 2834662

MRI findings and peripheral neuropathy in Lowe's syndrome.

L Charnas1, J Bernar, G H Pezeshkpour, M Dalakas, G S Harper, W A Gahl.   

Abstract

Neurologic features of oculocerebrorenal (Lowe) syndrome include mental retardation, hypotonia, and areflexia. We performed a sural nerve biopsy, computerized tomography (CT) scan, and magnetic resonance imaging (MRI) scan on a 14-year-old boy with oculocerebrorenal syndrome with very mild renal disease. The nerve biopsy exhibited decreased number of myelinated fibers, normal myelination on remaining axons without redundant basal lamina, and no evidence of active degeneration or regeneration. MRI scan revealed diffuse and irregular foci of increased T2 signal with sparing of commissural fibers, pyramidal tracts, and cerebellar white matter. We conclude that both a peripheral axonopathy and a central demyelinating or gliotic process occurs in oculocerebrorenal syndrome in the absence of the severe renal disease that often complicates this disorder.

Entities:  

Mesh:

Year:  1988        PMID: 2834662     DOI: 10.1055/s-2008-1052393

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  8 in total

1.  Periventricular white matter cystic lesions in Lowe (oculocerebrorenal) syndrome. A new MR finding.

Authors:  L A Demmer; F J Wippold; S B Dowton
Journal:  Pediatr Radiol       Date:  1992

2.  Central nervous system and renal investigations in patients with Lowe syndrome.

Authors:  S M Pueschel; A S Brem; P Nittoli
Journal:  Childs Nerv Syst       Date:  1992-02       Impact factor: 1.475

Review 3.  The 5-phosphatase OCRL in Lowe syndrome and Dent disease 2.

Authors:  Maria Antonietta De Matteis; Leopoldo Staiano; Francesco Emma; Olivier Devuyst
Journal:  Nat Rev Nephrol       Date:  2017-07-03       Impact factor: 28.314

4.  Anesthetic management for a patient with oculocerebrorenal (Lowe's) syndrome.

Authors:  Hisao Komatsu; Masatomo Sakakibara; Yutaka Yoshimura; Hiroyuki Kinoshita; Satoshi Yokono; Kenji Ogli
Journal:  J Anesth       Date:  1994-03       Impact factor: 2.078

5.  Characterization of 28 novel patients expands the mutational and phenotypic spectrum of Lowe syndrome.

Authors:  Florian Recker; Marcin Zaniew; Detlef Böckenhauer; Nunzia Miglietti; Arend Bökenkamp; Anna Moczulska; Anna Rogowska-Kalisz; Guido Laube; Valerie Said-Conti; Belde Kasap-Demir; Anna Niemirska; Mieczysław Litwin; Grzegorz Siteń; Krystyna H Chrzanowska; Małgorzata Krajewska-Walasek; Sidharth K Sethi; Velibor Tasic; Franca Anglani; Maria Addis; Anna Wasilewska; Maria Szczepańska; Krzysztof Pawlaczyk; Przemysław Sikora; Michael Ludwig
Journal:  Pediatr Nephrol       Date:  2014-12-06       Impact factor: 3.714

Review 6.  Lowe syndrome.

Authors:  Mario Loi
Journal:  Orphanet J Rare Dis       Date:  2006-05-18       Impact factor: 4.123

Review 7.  The oculocerebrorenal syndrome of Lowe: an update.

Authors:  Arend Bökenkamp; Michael Ludwig
Journal:  Pediatr Nephrol       Date:  2016-03-24       Impact factor: 3.714

Review 8.  Lowe syndrome identified in the offspring of an oocyte donor who was an unknown carrier of a de novo mutation: a case report and review of the literature.

Authors:  P Tatsi; G E Papanikolaou; T Chartomatsidou; I Papoulidis; A Athanasiadis; R Najdecki; E Timotheou
Journal:  J Med Case Rep       Date:  2019-11-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.